Kamada/KMDA

$5.16

0.39%
-
1D1W1MYTD1YMAX

About Kamada

Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Ticker

KMDA

Sector

Healthcare

Trading on

NASDAQ

Industry

Biotechnology & Drugs

CEO

Amir London

Employees

378

Headquarters

Rehovot, Israel

Kamada Metrics

BasicAdvanced
$295.42M
Market cap
29.24
P/E ratio
$0.18
EPS
1.05
Beta
-
Dividend rate
$295.42M
1.05346
$6.53
$4.08
21.57K
3.427
1.643
3.048
3.615
16.411
15.36%
2.45%
3.94%
3%
29.244
2.073
1.211
1.211
10.19%
439.04%
2.27%
-26.23%

What the Analysts think about Kamada

Analyst Ratings

Majority rating from 1 analysts.
Buy

Price Targets

Average projection from 2 analysts.
132.56% upside
High $13.00
Low $11.00
$5.16
Current price
$12.00
Average price target

Kamada Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
13.73% profit margin
QuarterlyAnnual
Q4 23
QoQ growth
Revenue
$36.4M
-3.96%
Net income
$5M
56.25%
Profit margin
13.73%
62.68%

Kamada Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 80%
QuarterlyAnnual
Q1 23
Q2 23
Q3 23
Q4 23
Q1 24
Actual
-$0.04
$0.04
$0.06
$0.09
-
Expected
$0.03
$0.02
$0.03
$0.05
$0.06
Surprise
-260%
100%
100%
80%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. Fundamental data, financials and analyst ratings are sourced from Refinitiv.

Upcoming events

FAQs

What’s the current market cap for Kamada stock?

Kamada (KMDA) has a market cap of $295.42M as of April 15, 2024.

What is the P/E ratio for Kamada stock?

The price to earnings (P/E) ratio for Kamada (KMDA) stock is 29.24 as of April 15, 2024.

Does Kamada stock pay dividends?

No, Kamada (KMDA) stock does not pay dividends to its shareholders as of April 15, 2024.

When is the next Kamada dividend payment date?

Kamada (KMDA) stock does not pay dividends to its shareholders.

What is the beta indicator for Kamada?

Kamada (KMDA) has a beta rating of 1.05. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

What is the Kamada stock price target?

The target price for Kamada (KMDA) stock is $12, which is 132.56% above the current price of $5.16. This is an average based on projections from 2 analysts, and represents their view of what the stock price could be in 12 or 18 months. This should not be seen as investment advice - Lightyear does not carry out investment research.

Buy or sell Kamada stock

Buy or sell Kamada stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing